Detalhe da pesquisa
1.
Patterns of Relapse after Definitive Chemoradiotherapy in Stage II/III (Non-T4) Esophageal Squamous Cell Carcinoma.
Oncology
; 94(1): 47-54, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29080886
2.
A multicenter phase II study of the stop-and-go modified FOLFOX6 with bevacizumab for first-line treatment of patients with metastatic colorectal cancer.
Invest New Drugs
; 30(5): 2026-31, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22160802
3.
Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer.
Clin Cancer Res
; 14(10): 3022-9, 2008 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18483367
4.
A phase i study of bolus 5-fluorouracil and leucovorin combined with weekly paclitaxel (FLTAX) as first-line therapy for advanced gastric cancer.
Jpn J Clin Oncol
; 38(8): 540-6, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18628316
5.
Sequential chemotherapy with methotrexate and 5-fluorouracil for chemotherapy-naive advanced gastric cancer with disseminated intravascular coagulation at initial diagnosis.
J Cancer Res Clin Oncol
; 136(2): 243-8, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19727819